PARTNERING OPPORTUNITIES

Icagen has maintained an active partnering program throughout its growth phase. Current opportunities focus on specific targets or specific compounds for broad indications within the Company's therapeutic areas of epilepsy, asthma, pain and inflammation.

For more information on these programs, please visit the following sections of our website:

Epilepsy

Asthma
Pain Disorders
Inflammation

To contact Icagen's Business Development Team, please write to:

US Mail:

Dr. Gregory Shotzberger

Vice President, Business Development

4222 Emperor Blvd., Suite 350

Durham, NC 27703

E-Mail: gshotzberger@icagen.com